Brian T. Powl

Insider Reports History

Location
San Diego, CA
Signature
Teresa Bair, Attorney-in-fact for Brian Powl
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian T. Powl:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kura Oncology, Inc. Chief Commercial Officer Common Stock 189,689 $1,970,773 $10.39 02 Jan 2026 Direct
FATE THERAPEUTICS INC Chief Commercial Officer Stock Option (Right to Buy) 425,000 $1,160,250 $2.73 06 Feb 2023 Direct
FATE THERAPEUTICS INC Chief Commercial Officer Common Stock 41,146 $179,808 $4.37 05 Jul 2023 Direct
Kura Oncology, Inc. Chief Commercial Officer Option to purchase common stock 100,000 02 Jan 2026 Direct

Insider Reports Filed by Brian T. Powl

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KURA Kura Oncology, Inc. 02 Jan 2026 2 $0 4 Chief Commercial Officer 06 Jan 2026, 16:30
KURA Kura Oncology, Inc. 13 Nov 2025 2 -$99,329 4 Chief Commercial Officer 14 Nov 2025, 20:00
KURA Kura Oncology, Inc. 27 Sep 2025 2 -$79,505 4 Chief Commercial Officer 29 Sep 2025, 19:30
KURA Kura Oncology, Inc. 28 Jan 2025 1 -$12,461 4 Chief Commercial Officer 28 Jan 2025, 20:38
KURA Kura Oncology, Inc. 02 Jan 2025 2 $0 4 Chief Commercial Officer 06 Jan 2025, 16:07
KURA Kura Oncology, Inc. 02 Jan 2024 2 $0 4 Chief Commercial Officer 04 Jan 2024, 16:07
KURA Kura Oncology, Inc. 14 Aug 2023 1 $0 4 Chief Commercial Officer 16 Aug 2023, 17:09
KURA Kura Oncology, Inc. 14 Aug 2023 0 $0 3 Chief Commercial Officer 16 Aug 2023, 17:08
FATE FATE THERAPEUTICS INC 05 Jul 2023 1 -$18,769 4 Chief Commercial Officer 06 Jul 2023, 17:19
FATE FATE THERAPEUTICS INC 06 Feb 2023 1 $0 4 Chief Commercial Officer 07 Feb 2023, 15:16
FATE FATE THERAPEUTICS INC 27 Jun 2022 2 $0 4 Chief Commercial Officer 29 Jun 2022, 17:02
FATE FATE THERAPEUTICS INC 27 Jun 2022 0 $0 3 Chief Commercial Officer 29 Jun 2022, 17:01